REAL-TIME ANALYZERS INC
Tacrolimus At-home Saliva Test (TAST): a lateral-flow assay device with smartphone app for measuring tacrolimus drug levels in saliva
- Sector
- Medtech
- Headquarters
- Middletown, CT
- Total capital
- $3.1M
- Federal grants
- $3.1M
- 5 awards · 2015–2023
- Rank in peer group#428 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal grantDefense · Phase II · At-Home Minimally Invasive Tacrolimus Plasma Level Monitoring Device$1.3M
- Federal grantDefense · Phase II · Immunosuppressant Drug Monitor$1.0M
- Federal grantDefense · Phase I · Field-Level Aviation Fuel Contamination Analyzer$150K
- Federal grantDefense · Phase I · Immunosuppressant Drug Monitor$150K
- Federal grantHealth and Human S · Phase II · Saliva Analyzer for Diagnosing SRD Patient Drug Use$503K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Linked publications#19 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 8- PendingMethod For Effecting The Rapid Release Of A Signature Chemical From Bacterial Endospores, And For Detection ThereofUSPTOApplication PCTUS2007001090
- PendingMethod And Apparatus For Rapid Extraction And Analysis, By Sers, Of Drugs In SalivaUSPTOApplication PCTUS2005032621
- PendingMethod For Quantitative Surface-enhanced Raman Spectroscopy Using A Chemical ReferenceUSPTOApplication PCTUS2005018428
Show all 8 patent records
- Method For Effecting The Rapid Release Of A Signature Chemical From Bacterial Endospores, And For Detection ThereofApplication PCTUS2007001090Pending
- Method And Apparatus For Rapid Extraction And Analysis, By Sers, Of Drugs In SalivaApplication PCTUS2005032621Pending
- Method For Quantitative Surface-enhanced Raman Spectroscopy Using A Chemical ReferenceApplication PCTUS2005018428Pending
- Method And Apparatus For Performing Sers Analysis Using A Chemical ReferenceApplication PCTUS2005018498Pending
- Simultaneous Chemical Separation And Surface-enhanced Raman Spectral DetectionApplication PCTUS2005001007Pending
- Simultaneous Chemical Separation And Plural-point Surface-enhanced Raman Spectral DetectionApplication PCTUS2005001008Pending
- Simultaneous Chemical Separation And Surface-enhanced Raman Spectral Detection Using Metal-doped Sol-gelsApplication PCTUS2004000957Pending
- Chemical Separation And Plural-point, Surface-enhanced Raman Spectral Detection Using Metal-doped Sol-gelsApplication PCTUS2004000956Pending
Recent research by its founders
- Detecting Fentanyl in Patient Samples Using Surface‐Enhanced Raman Spectroscopy20250 cites
- Detection of Foodborne Pathogens on Surfaces and in Food by <scp>SERRS</scp>20250 cites
- Surface‐Enhanced Raman Spectroscopy Theory20250 cites
Related companies, and why
- PEAK DIAGNOSTIC PARTNERS LLCSimilar federal contract value in Medtech · null in contracts
- Eye To Eye Telehealth, Inc.Similar federal contract value in Medtech · null in contracts
- PROPEL ORTHODONTICS, LLCSimilar federal contract value in Medtech · null in contracts
- DYNUPOL, INC.Similar federal contract value in Medtech · null in contracts
- Microbial Medical, Inc.Similar federal contract value in Medtech · null in contracts
- ORALMR LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .